Identify new medications that have recently been FDA approved
Describe the indication, mechanisms of action, typical doses, common adverse reactions, and contraindications associated with these medications
Discuss clinical trial data for these medications
Description:
This presentation will provide information on 2024-2025 FDA-approved drugs. These drugs provide new treatment options for patients and advances in healthcare for the American public. This will be a comprehensive review that will identify the new agents, describe the indication, mechanism of action, and more, in addition to explaining to patients how to maximize the products' therapeutic effects.
Members: FREE Non-Members: $25.00
Date: Sunday, May 18 Time: 6:00 pm - 7:00 pm
ACPE accredited for 1.0-hour ACPE#
Upcoming Live Webinar Events
Bridging the Gaps on Medication Disparities with Stephanie Kiser on Sunday, July 20
Important! The Emergency Prescription Assistance Program (EPAP), activated in response to Hurricane Helene, will officially end on May 31. NC DHHS has issued a memo with important information for pharmacists and clinicians regarding the conclusion of the program, along with resources to support patients who have been utilizing EPAP.You can access it directly on the NC DHHS Hurricane Helene Provider Resources webpage under Notices and Alerts. Please review and share this information with your teams and patients as needed.
